Microcap Ledger Orasure Technologies Inc $OSUR
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Bethlehem, PA
- Fiscal year end
- December 31
- Shares outstanding
- 68,968,627 [10-Q 2026-08-07]
What the company doesAI summary of filing
OraSure Technologies develops, manufactures, and sells diagnostic products and sample management solutions. The company's diagnostic products include rapid point-of-care tests for HIV, Hepatitis C, syphilis, sickle cell disease, COVID-19, and Ebola, sold to clinical laboratories, hospitals, clinics, government agencies, and consumers in both professional and over-the-counter formats in the United States and internationally. The company also develops and sells sample collection and stabilization devices for genomic, proteomic, and microbiome applications used by academic researchers, commercial laboratories, and pharmaceutical companies. OraSure is a revenue-generating company with multiple product lines contributing significantly to its financial performance. [10-K 2026-03-09]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $58.56M | −$16.13M | −$23.82M | $160.58M | [10-Q 2026-08-07] |
| FY ended Dec 2025 | $115.02M | −$68.73M | −$49.02M | $199.28M | [10-K 2026-03-09] |
| FY ended Dec 2024 | $185.83M | −$19.50M | $27.37M | $267.76M | [10-K 2026-03-09] |
- Quarterly cash burn
- −$11.91M
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-31 | 74,594,154 | [10-Q 2024-11-06] |
| 2025-02-24 | 74,800,131 | [10-K 2025-03-07] |
| 2025-05-02 | 74,800,131 | [10-Q 2025-05-07] |
| 2025-07-31 | 73,136,987 | [10-Q 2025-08-06] |
| 2025-10-31 | 71,733,530 | [10-Q 2025-11-05] |
| 2026-02-28 | 69,126,173 | [10-K 2026-03-09] |
| 2026-04-30 | 68,848,553 | [10-Q 2026-05-08] |
| 2026-07-31 | 68,968,627 | [10-Q 2026-08-07] |
- Shelf registration
- S-3 filed 2025-05-20; declared effective 2025-05-29 [S-3 2025-05-20]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-29 | Boyd Steven Kyle | grant | 4,797 | $3.88 | [4 2026-10-01] |
| 2026-09-06 | Kenny John P. | other | 5,116 | $3.43 | [4 2026-09-09] |
| 2026-06-26 | Boyd Steven Kyle | grant | 3,666 | $4.43 | [4 2026-06-30] |
| 2026-06-03 | Mcmahon Robert W. | grant | 46,106 | — | [4 2026-06-05] |
| 2026-06-03 | Gagliano Nancy J | grant | 46,106 | — | [4 2026-06-05] |
| 2026-06-03 | Marmora Lelio | grant | 46,106 | — | [4 2026-06-05] |
| 2026-06-03 | Kenny John P. | grant | 46,106 | — | [4 2026-06-05] |
| 2026-06-03 | Bertrand John D. | grant | 46,106 | — | [4 2026-06-05] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-17 | 13D | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-07 | 10-Q | Quarterly report |
| 2026-08-05 | 8-K | Results of operations |
| 2026-07-31 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-06-11 | 8-K | Other events |
| 2026-06-03 | 8-K | Director or officer change; Charter, bylaws or fiscal year change; Shareholder vote results |
| 2026-05-08 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-04-30 | DEF 14A | Proxy statement |
| 2026-04-30 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-04-20 | PRE 14A | Proxy statement |
Alerts for $OSUR
Email me when Orasure Technologies Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.